Effects of adrenergic blocking agents on gastric secretion and stress-induced gastric ulcer in rats.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa; D006471:Gastrointestinal Hemorrhage; D008297:Male; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013276:Stomach Ulcer / Q000209:etiology*; D013312:Stress, Physiological / Q000150:complications*; D013565:Sympatholytics / Q000494:pharmacology*; D014043:Tolazoline / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D015016:Yohimbine; D003983:Dibenzylchlorethamine; D011433:Propranolol; D014043:Tolazoline; D004878:Ergotamine; D010646:Phentolamine